TTK Healthcare Limited has announced the closure of its trading window effective from April 1, 2025. In compliance with SEBI’s (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Conduct, this decision prohibits designated persons and their immediate relatives from trading in the company’s securities. The trading window will remain closed until 48 hours after the company announces its audited financial results for the financial year ending March 31, 2025.
The date for the board meeting to approve the financial results will be communicated in due course. This action reflects TTK Healthcare’s commitment to maintaining transparency and complying with SEBI’s insider trading regulations.
Summary in Points: • Trading Window Closure Date: April 1, 2025
• Affected Personnel: Designated persons and immediate relatives
• Duration of Closure: Until 48 hours after financial results are declared
• Financial Results: For the financial year ending March 31, 2025
• Board Meeting Date: To be announced later
Effect on Share Market: The trading window closure is unlikely to affect TTK Healthcare’s stock price in the short term, as such actions are routine before financial announcements. However, investors will be keen to review the financial results, which may drive stock market activity once the window reopens.
Company Overview: TTK Healthcare Limited is a prominent healthcare and consumer products company in India. Known for its range of medical devices, healthcare products, and consumer goods, TTK Healthcare has established itself as a trusted brand in the Indian market. With a commitment to quality and innovation, the company continues to strengthen its market presence.
📉 Stock Market Disclaimer
Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
